MARY HAMMONDS: Open Payments
NPI 1346565009 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 27 payments from 8 companies in 2025. Trend: 2023 $1,108 · 2024 $1,387 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $193 |
| ABBVIE INC. | 10 | $136 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Lundbeck LLC | 2 | $50 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Abbott Laboratories | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: FARXIGA, VRAYLAR, REXULTI, TRELEGY ELLIPTA, CAPLYTA, UBRELVY, AIRSUPRA, Sunosi.
Industry payments across TN — which companies pay providers there.
